Note 13 - Segment Information (Tables)

6 Months Ended

Jun. 29, 2024

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Thirteen Weeks Ended June 29, 2024	Specialty Health Care		Engineering		Life Sciences and IT		Corporate			Total
Revenue	$	36,932	$	22,508	$	9,724	$	-		$	69,164
Cost of services		26,293		16,542		6,328		-			49,163
Gross profit		10,639		5,966		3,396		-			20,001
Selling, general and administrative		7,254		4,049		2,242		-			13,545
Depreciation and amortization of property and equipment		127		162		43		-			332
Amortization of acquired intangible assets		-		-		46		-			46
Costs associated with potential stock issuance		-		-		-		259			259
Operating income (loss)	$	3,258	$	1,755	$	1,065	$	(259	)	$	5,819
Total assets as of June 29, 2024	$	40,236	$	47,387	$	20,390	$	10,265		$	118,278
Property and equipment acquired	$	60	$	45	$	6	$	287		$	398

Thirteen Weeks Ended July 1, 2023	Specialty Health Care		Engineering		Life Sciences and IT		Corporate		Total
Revenue	$	35,528	$	21,014	$	10,493	$	-	$	67,035
Cost of services		25,727		16,192		6,356		-		48,275
Gross profit		9,801		4,822		4,137		-		18,760
Selling, general and administrative		6,043		4,380		2,300		-		12,723
Depreciation and amortization of property and equipment		92		116		34		-		242
Amortization of acquired intangible assets		-		-		46		-		46
Operating income	$	3,666	$	326	$	1,757	$	-	$	5,749
Total assets as of July 1, 2023	$	39,961	$	42,668	$	17,947	$	4,961	$	105,537
Property and equipment acquired	$	29	$	190	$	2	$	7	$	228

Twenty-Six Weeks Ended June 29, 2024	Specialty Health Care		Engineering		Life Sciences and IT		Corporate			Total
Revenue	$	75,114	$	46,013	$	19,976	$	-		$	141,103
Cost of services		53,409		34,540		12,786		-			100,735
Gross profit		21,705		11,473		7,190		-			40,368
Selling, general and administrative		14,718		8,242		4,784		-			27,744
Depreciation and amortization of property and equipment		231		307		81		-			619
Amortization of acquired intangible assets		-		-		91		-			91
Costs associated with potential stock issuance		-		-		-		259			259
Operating income (loss)	$	6,756	$	2,924	$	2,234	$	(259	)	$	11,655
Total assets as of June 29, 2024	$	40,236	$	47,387	$	20,390	$	10,265		$	118,278
Property and equipment acquired	$	167	$	244	$	20	$	636		$	1,067

Twenty-Six Weeks Ended July 1, 2023	Specialty Health Care		Engineering			Life Sciences and IT		Corporate		Total
Revenue	$	74,658	$	39,504		$	19,997	$	-	$	134,159
Cost of services		53,185		30,365			12,555		-		96,375
Gross profit		21,473		8,869			7,442		-		37,784
Selling, general and administrative		13,241		8,298			4,580		-		26,119
Depreciation and amortization of property and equipment		199		244			70		-		513
Amortization of acquired intangible assets		-		-			91		-		91
Gain on sale of assets		-		(395	)		-		-		(395	)
Operating income	$	8,033	$	722		$	2,701	$	-	$	11,456
Total assets as of July 1, 2023	$	39,961	$	42,668		$	17,947	$	4,961	$	105,537
Property and equipment acquired	$	47	$	478		$	19	$	15	$	559

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	June 29, 2024		July 1, 2023		June 29, 2024		July 1, 2023
Revenue
United States	$	63,569	$	62,797	$	130,420	$	126,120
Canada		1,618		1,832		3,087		3,413
Puerto Rico		2,019		1,540		4,020		3,102
Europe		1,958		866		3,576		1,524
	$	69,164	$	67,035	$	141,103	$	134,159

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	June 29, 2024		December 30, 2023
Total assets
United States	$	110,102	$	110,781
Canada		1,763		1,880
Puerto Rico		2,453		3,476
Europe		3,960		4,347
	$	118,278	$	120,484